Contact

Carden Flux Home About Services Safety Checklist Cardiac Risk Primer Clinic Verification Guide Contact Signal check / 2026 Ambio Ibogaine Clinic: A Safety Checklist Ibogaine decisions demand more than compelling claims. This guide focuses on the questions that matter before considering a high-risk treatment setting: cardiac screening, medication review, clinical monitoring, emergency readiness, and informed consent. Independent guidance: Carden Flux is not a clinic. This checklist is designed to help people considering ibogaine, their families, and anyone comparing international treatment options ask precise safety questions. 01 / start with risk Safety is the first claim to verify. Ambio Life Sciences describes programs in Baja California and Malta. That setting does not remove ibogaine’s core risks. In the United States, ibogaine remains a Schedule I substance under the DEA drug scheduling framework , while patients may encounter different legal and clinical conditions abroad. CARDIAC Confirm cardiac exclusion rules Ask which ECG findings, medical histories, electrolyte abnormalities, and medication combinations mean treatment should not proceed. Ibogaine-associated QT prolongation and arrhythmia risk require a conservative approach. REVIEW Map every medication and substance Provide a complete list of prescriptions, over-the-counter products, supplements, alcohol, and drug use. Interactions, withdrawal, and recent exposure can change risk substantially. MONITOR Ask who is watching, and how Clarify continuous monitoring, the clinical team’s role during dosing, escalation procedures, and what equipment is immediately available if a cardiac complication occurs. 02 / cardiac reality Potential does not cancel cardiotoxicity. Ibogaine is discussed for addiction and neurologic conditions because of its unusual pharmacology, but its cardiac risk is not theoretical. The long QT syndrome overview explains why delayed electrical recovery in the heart can create a dangerous r